KPV

KPV

Research Compound
£49.99

Description

KPV (Lys-Pro-Val) is a naturally occurring C-terminal tripeptide fragment of alpha-Melanocyte Stimulating Hormone (α-MSH), a peptide with well-established immunomodulatory and anti-inflammatory properties. KPV retains the core anti-inflammatory activity of its parent peptide whilst offering superior stability and a markedly simpler molecular structure. Its small size and favourable physicochemical profile have made it a subject of growing interest in gastrointestinal, dermatological, and systemic inflammation research.

 

Product Specifications



Compound  KPV (Lys-Pro-Val)
Form  Capsule
Capsules per bottle  60
Concentration  500mcg per capsule
Total yield  30,000mcg (30mg) per bottle
CAS Number  66003-86-9
Purity  ≥98% (HPLC verified)
Storage  Store in a cool, dry place away from direct sunlight. Refrigeration recommended for long-term storage.



Research Background

KPV exerts its effects primarily through direct interaction with melanocortin receptors (MC1R, MC3R) and via intracellular inhibition of pro-inflammatory signalling cascades, including NF-κB pathway suppression. Its ability to penetrate epithelial barriers and act locally within mucosal tissue has positioned it as a particularly valuable tool in gut inflammation research. Key areas of active scientific investigation include:

  • Inflammatory bowel disease models — reduction of colonic inflammation markers in preclinical models of ulcerative colitis and Crohn's-like disease, including downregulation of TNF-α, IL-6, and IL-1β
  • Gut mucosal integrity — research into epithelial barrier function, tight junction preservation, and intestinal permeability under inflammatory challenge
  • Melanocortin receptor signalling — investigation of MC1R and MC3R-mediated anti-inflammatory pathways in immune cell populations
  • Dermatological inflammation — preclinical models examining wound healing, psoriasis, and atopic dermatitis via topical and systemic administration routes
  • Systemic immunomodulation — broad suppression of pro-inflammatory cytokine cascades across multiple tissue types without immunosuppressive side effect profiles observed in conventional agents
  • Oral bioavailability research — study of tripeptide stability under gastrointestinal conditions and transepithelial absorption kinetics

 

Quality Assurance

Every batch of NueCog KPV is manufactured using solid-phase peptide synthesis (SPPS) and undergoes rigorous third-party analytical testing including HPLC purity analysis and mass spectrometry confirmation. Certificate of Analysis (CoA) available on request.

 

Intended Use

This product is sold strictly for laboratory and in-vitro research purposes only. It is not intended for human consumption, veterinary use, or diagnostic application. Not for sale to minors. This product is not a medicine, food supplement, or drug.

Important Notice:

This product is sold strictly for research purposes only. Not intended for human consumption. By purchasing, you confirm you are a qualified researcher operating in a proper laboratory setting.